All of the 5,600,000 options were approved with an exercise price of $0.14, being the closing price of the Corporation's shares on the TSX Venture Exchange on the date preceding the date such grants were approved by the board. 4,325,000 of the options issued to directors and officers vest immediately, with 75,000 of such options vesting two years from the date of grant. All of such options issued to directors and officers have a term of five years from the date of issuance.
Genoil is a technology development company providing solutions to the oil and gas industry through the use of proprietary technologies. The Genoil Hydroconversion Upgrader is designed to economically convert heavy crude oil into more valuable light synthetic crude, high in yields of transport fuels, while significantly reducing the sulfur, nitrogen and other contaminants in the oil. Genoil's shares are listed on the TSX Venture Exchange under the symbol GNO, as well as on the OTC Bulletin Board under GNOLF.OB.
ADVISORY: The TSX Venture Exchange has neither approved nor disapproved of the information contained herein.
For further information
on Genoil Inc. visit www.genoil.net
David Lifschultz, Chairman and CEO, (914) 834-7794, (914) 393-5800
Copyright © 2009 CNW Group. All rights reserved. All the news releases provided by CNW Group are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.